Device Trial Radar · NCT04054817
ACRO Biocornea Clinical Trial in Taiwan
Last checked: Nov 20, 2026Latest source record: Apr 19, 2023 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
6
Actual
Start
Nov 2, 2020
Primary completion
Oct 5, 2022
Study completion Mar 6, 2023
Sponsor
- Lead sponsor
- ACRO Biomedical Co. LtdNot on our public-company list
- Sponsor type
- Industry
- First posted
- Aug 13, 2019
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- No
- Who can join
- All sexes, from 20 years, up to 80 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The goal of this clinical trial is to investigate the safety and clinical performance of ABCcolla Collagen Ophthalmic Matrix used for anterior lamellar keratoplasty in patients suffering from corneal ulcer. Participants will undergo keratoplasty using the investigational product and be followed up for 24-week observation (total of 10 times).
Conditions
- Corneal Ulcer
Interventions
Lamellar keratoplasty-ABCcolla® Collagen Ophthalmic MatrixDevice
Lamellar keratoplasty was done by removing stromal layer, ABCcolla® Collagen Ophthalmic Matrix was sutured to the defective part of the cornea.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Incidence rate of irreversible graft dissociation or irreversible graft rejection within 6 months.Time frame: After the surgery, patients will be examined for follow-up observation for 24 weeks.
Locations
3 sites in 1 country. Site status is shown where the registry gives one.
Kaohsiung Medical University Chung-Ho Memorial Hospital
Kaohsiung City, Taiwan
Kaohsiung Veterans General Hospital
Kaohsiung City, Taiwan
Tri-Service General Hospital
Taipei, Taiwan
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.